Activity in this selectionOct 28, 2026 · Oct 22, 2026
- Rounds participated in
- 1
- Confirmed lead rounds
- 1
All roles disclosed- New companies
- 1
First participation on record · 0 follow-on- Funding in participating rounds
- $2.5M
1 disclosed · full round size, not this investor’s share
Rounds
1 in this selectionAtlas BioAtlas Bio develops AI models that simulate patient responses to help biopharma teams assess drug development decisions.
$2.5MPreviously undisclosed pre-seed Lead